Drug Approval Package

Vimpat (lacosamide) Injection & Tablets
Company: Schwarz Biosciences, Inc.
Application No.:  022253 & 022254
Approval Date: 10/28/2008

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.

Approval Letter(s) (PDF) 

• Summary Review (PDF) 

• Officer/Employee List (PDF) 

• Cross Disipline Team Leader Review (PDF) 

• Printed Labeling (PDF) 

• Medical Review(s) 

  • Part 1 (PDF)
  • Part 2 (PDF)
  • Part 3 (PDF)
  • Part 4 (PDF)

• Chemistry Review(s) (PDF) 

• Environmental Assessment (PDF) 

• Pharmacology Review(s) 

  • Part 1 (PDF)
  • Part 2 (PDF)
  • Part 3 (PDF)

• Statistical Review(s) (PDF) 

• Microbiology Review(s) (PDF) 

• Clinical Pharmacology Biopharmaceutics Review(s) 

  • Part 1 (PDF) 
  • Part 2 (PDF) 
  • Part 3 (PDF)
  • Part 4 (PDF) 
  • Part 5 (PDF)  

• Risk Assessment and Risk Mitigation Review(s) (PDF) 

• Proprietary Name Review(s) (PDF) 

• Administrative Document(s) & Correspondence 

  • Part 1 (PDF) 
  • Part 2 (PDF)  

Date created: December 17, 2008

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.